[go: up one dir, main page]

SK14452003A3 - Spôsob výroby pioglitazonu ako antidiabetika - Google Patents

Spôsob výroby pioglitazonu ako antidiabetika Download PDF

Info

Publication number
SK14452003A3
SK14452003A3 SK1445-2003A SK14452003A SK14452003A3 SK 14452003 A3 SK14452003 A3 SK 14452003A3 SK 14452003 A SK14452003 A SK 14452003A SK 14452003 A3 SK14452003 A3 SK 14452003A3
Authority
SK
Slovakia
Prior art keywords
formula
compound
group
carried out
ethyl
Prior art date
Application number
SK1445-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Ale� Halama
Ludmila Hejtm�Nkov�
Petr Lustig
Jind�Ich Richter
Lucie Sr��Ov�
Josef Jirman
Original Assignee
Liva, A. S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CZ20011502A external-priority patent/CZ20011502A3/cs
Priority claimed from CZ20011501A external-priority patent/CZ20011501A3/cs
Application filed by Liva, A. S. filed Critical Liva, A. S.
Publication of SK14452003A3 publication Critical patent/SK14452003A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
SK1445-2003A 2001-04-26 2002-04-25 Spôsob výroby pioglitazonu ako antidiabetika SK14452003A3 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CZ20011502A CZ20011502A3 (cs) 2001-04-26 2001-04-26 Způsob výroby antidiabetika
CZ20011501A CZ20011501A3 (cs) 2001-04-26 2001-04-26 Způsob výroby meziproduktu pro výrobu antidiabetika
PCT/CZ2002/000024 WO2002088120A1 (fr) 2001-04-26 2002-04-25 Procede de production d'un antidiabetique

Publications (1)

Publication Number Publication Date
SK14452003A3 true SK14452003A3 (sk) 2004-04-06

Family

ID=25746959

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1445-2003A SK14452003A3 (sk) 2001-04-26 2002-04-25 Spôsob výroby pioglitazonu ako antidiabetika

Country Status (11)

Country Link
US (1) US7009057B2 (fr)
EP (1) EP1387843B1 (fr)
AT (1) ATE355286T1 (fr)
AU (1) AU2002311057A1 (fr)
DE (1) DE60218449D1 (fr)
EE (1) EE200300519A (fr)
HU (1) HUP0400091A2 (fr)
PL (1) PL363738A1 (fr)
RU (1) RU2281285C2 (fr)
SK (1) SK14452003A3 (fr)
WO (1) WO2002088120A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8993773B2 (en) 2002-07-16 2015-03-31 Cadila Healthcare Limited Process to prepare pioglitazone via several novel intermediates
AU2003272072A1 (en) 2002-07-16 2004-02-02 Cadila Healthcare Limited A process to prepare pioglitazone via several intermediates.
WO2004108721A1 (fr) * 2003-04-01 2004-12-16 Sun Pharmaceutical Industries Limited Procede servant a preparer 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione
ES2219180B1 (es) * 2003-05-09 2006-03-01 Medichem, S.A. Compuesto intermedio util para la preparacion de pioglitazona.
WO2004101560A1 (fr) * 2003-05-13 2004-11-25 Synthon B.V. Procedes de fabrication de derives de thiazolidinedione et composes associes
US7230016B2 (en) 2003-05-13 2007-06-12 Synthon Ip Inc. Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
US20070078170A1 (en) * 2003-08-28 2007-04-05 Khanduri Chandra H Process for the preparation of pioglitazone
CN1319956C (zh) * 2003-09-12 2007-06-06 深圳市海粤门生物科技开发有限公司 一种噻唑烷二酮的衍生物及其药用制剂的制备方法和应用
EP1716144A2 (fr) 2004-02-20 2006-11-02 Synthon B.V. Procedes pour produire de la pioglitazone et composes issus de ces procedes
US7402713B2 (en) * 2006-03-07 2008-07-22 E.I. Du Pont De Nemours And Company Processes for conversion of tyrosine to p-hydroxystyrene and p-acetoxystyrene
ES2654908T3 (es) 2006-03-16 2018-02-15 Metabolic Solutions Development Company Llc Análogos de tiazolidindiona para el tratamiento de enfermedades mediadas por una inflamación metabólica
EP2001469B1 (fr) 2006-03-16 2012-05-23 Metabolic Solutions Development Company LLC Analogues de thiazolidinedione
KR100791400B1 (ko) 2006-09-06 2008-01-07 동우신테크 주식회사 티아졸리딘디온 유도체의 제조방법
US8304441B2 (en) 2007-09-14 2012-11-06 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic diseases
BRPI0817096B8 (pt) 2007-09-14 2021-05-25 Cirius Therapeutics Inc análogo de tiazolidinodiona e composição farmacêutica que o compreende
WO2009148195A1 (fr) * 2008-06-02 2009-12-10 Daebong Ls, Ltd. Composé de 5(4-hydroxybenzyl)thiazolidine-2,4-dione comme produit intermédiaire dans la synthèse de composés à base de thiazolidinedione et procédé de préparation de celui-ci
ES2658168T3 (es) 2009-12-15 2018-03-08 Cirius Therapeutics, Inc. Sales de tiazolidinadiona ahorradoras de PPAR para el tratamiento de enfermedades metabólicas
CN108003090A (zh) * 2018-01-05 2018-05-08 白银亿尔精细化工有限公司 一种制备4-[2-(5-乙基-2-吡啶基)乙氧基]硝基苯的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57209274A (en) 1981-06-16 1982-12-22 Takeda Chem Ind Ltd Urea derivative, its preparation and its use
WO1986006069A1 (fr) * 1985-04-09 1986-10-23 Takeda Chemical Industries, Ltd. Derives de thiazolidinedione, leur procede de preparation et composition medicinale les contenant
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
JPS62205054A (ja) 1986-03-05 1987-09-09 Takeda Chem Ind Ltd 尿素誘導体
US5952509A (en) 1996-06-27 1999-09-14 Takeda Chemical Industries, Ltd. Production of benzaldehyde compounds
JP4316787B2 (ja) * 2000-01-11 2009-08-19 壽製薬株式会社 エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、

Also Published As

Publication number Publication date
PL363738A1 (en) 2004-11-29
EE200300519A (et) 2004-02-16
ATE355286T1 (de) 2006-03-15
DE60218449D1 (de) 2007-04-12
AU2002311057A1 (en) 2002-11-11
HUP0400091A2 (hu) 2004-06-28
WO2002088120A1 (fr) 2002-11-07
RU2281285C2 (ru) 2006-08-10
RU2003134542A (ru) 2005-06-10
WO2002088120B1 (fr) 2004-02-26
US7009057B2 (en) 2006-03-07
EP1387843A1 (fr) 2004-02-11
US20050043360A1 (en) 2005-02-24
EP1387843B1 (fr) 2007-02-28

Similar Documents

Publication Publication Date Title
SK14452003A3 (sk) Spôsob výroby pioglitazonu ako antidiabetika
US4450167A (en) 3-Quinoline carboxamides having anxiolytic activity
Gupta et al. Drugs acting on the central nervous system. Syntheses of substituted quinazolinones and quinazolines and triazepino-and triazocinoquinazolinones
US8263780B2 (en) Process for the preparation of 2-imino-thiazolidin-4-one derivatives
Toja et al. 3-Alkyl-2-aryl-3H-naphth [1, 2-d] imidazoles, a novel class of nonacidic antiinflammatory agents
EP0590793B1 (fr) Dérivés d'oxazolidine ayant des propriétés anti-diabète et anti-obésité, leur préparation et leur utilisation thérapeutique
IE50080B1 (en) 4-benzyl-and 4-benzoylimidazole derivatives,processes for their preparation and pharmaceutical compositions comprising the same
JPH06779B2 (ja) チアゾリジオン誘導体およびそれを含んでなる医薬組成物
SK109993A3 (en) Thiazolidinedione derivatives producing and use thereof
SK285233B6 (sk) Spôsob výroby tiazolidíndiónových derivátov
KR100712747B1 (ko) 치환된 벤조싸이아졸 유도체의 환화방법
OA11340A (en) Method for the synthesis of quinoline derivatives.
US4970210A (en) Triazinone lipoxygenase compounds
DE69625795T2 (de) Thiazolidinedionderivate mit antidiabetischen, hypolipidämischen und antihypertensiven Eigenschaften, Verfahren zu deren Herstellung und pharmazeutischen Zusammenstellungen, die sie enthalten
US5086052A (en) Substituted 1,4,5,6-tetrahydro-2H-pyridazin-3-one and -3-thione compounds having lipoxygenase inhibitory activity
EP0409692B1 (fr) Dérivés d'imino-2 hétérocyclylalkyl-3 benzothiazoline, leur préparation et les médicaments les contenant
CZ290353B6 (cs) Způsob výroby meziproduktu pro výrobu antidiabetika
Smicius et al. Reactions of 5-(6-Methyl-2, 4-dioxo-1, 2, 3, 4-tetrahydro-3-pyrimidinyl)-methyl-1, 3, 4-oxadiazole-2-thione with Electrophiles
US6555694B1 (en) Method for production of pyrrolidinone derivatives
CZ291364B6 (cs) Způsob výroby antidiabetika
CN101265216B (zh) 4-(取代乙氰基)-苯腙衍生物及其合成方法
HU218662B (hu) Tiazolidin-2,4-dion-származékok, az ezeket tartalmazó gyógyászati készítmények és eljárás előállításukra
Zidar et al. A Convenient Synthesis of 4-Benzyl-2-(2-(4-oxo-2-thioxothiazolidin-5-ylidene) ethyl)-2H-1, 4-benzoxazin-3 (4H)-ones and 5-(2-(4-Benzyl-3-oxo-3, 4-dihydro-2H-1, 4-benzoxazin-2-yl) ethylidene) thiazolidine-2, 4-diones.
US4390697A (en) Process for the preparation of triazoloquinazolinones
JPH0539276A (ja) イミノチアゾリン誘導体の製造法

Legal Events

Date Code Title Description
FB9A Suspension of patent application procedure